Complex PCI: Nothing Is Simple in Shock Patients!

Faculty and Program

	Benham N. Tehrani, MD, FSCAI Moderator To Support or Not to Support: MCS in AMI-Shock		Vikas Aggarwal, MBBS, FSCAI Getting In and Out Safely: Vascular Access and Closure in AMI-CS
	Rhian E. Davies, DO, FSCAI CTO’s in AMI-Shock: When and How to Treat		Hayder D. Hashim, MD, FSCAI Keeping Your Eyes Open: Role of Intravascular Imaging in Complex PCI
	Vicente Jimenez-Franco, MD What Is Complex and High Risk? Patient Population and Tools/Skillsets Needed to Treat		Saraschandra Vallabhajosyula, MD, MSc, FSCAI Chipping Away: Calcium Modification in Complex PCI
	Megha Prasad, MD How to Train for the Future

Learning Objectives

Upon completion of this activity, learners will be able to:

Implement protocols to identify at-risk patients and manage complications.
Describe best practices for use of mechanical circulatory support (MCS) in complex/high-risk PCI.
Identify available strategies and technologies for calcium modification.
Discuss roles and recommendations for the multi-disciplinary Heart Team to coronary revascularization.

Acknowledgment of Commercial Support

This activity is supported by an unrestricted educational grant from Boston Scientific.

Disclosures

Individuals in control of content reported the following relevant financial relationships with ineligible companies during the content development process for this activity. All relevant financial relationships were mitigated before the start of the activity.

Planner
Benham Tehrani: No relevant financial relationships with ineligible companies.

Faculty
VIkas Aggarwal, Vicente Jimenez-Franco, Benham Tehrani, and Saraschandra Vallabhajosyula: No relevant financial relationships with ineligible companies.

Rhian Davies: Abiomed, speaker. Boston Scientific, advisory board, speaker. Medtronic, speaker. Asahi intec, speaker. Teleflex, speaker. Terumo, speaker.

Hayder Hashim: Abbott, advisory board, consulting, PI, speaker. Boston Scientific, advisory board, PI, speaker. Philips, advisory board, speaker. Terumo, consulting, speaker

Staff
Kristen Perry, Rachel Pham, and Laura Porter: No relevant financial relationships with ineligible companies.

Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

Activity Timeline
Recording date: 9/20/2025
Publish date: 12/22/2025
Expiration date: 12/22/2028

SCAI's Independent Content

As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.

Planning Process
SCAI activities are developed by the SCAI Planners prior to and independent of commercial support. Members of the Education Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.

Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships. SCAI identifies relevant financial relationships and mitigates them before the activity begins.

Content Validation Statement

SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations. All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.

SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.

SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company.

SCAI's educational content is free of marketing or sales of products or services. Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education. 

SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.

Summary

Availability:

On-Demand

Access expires on Dec 22, 2028

Cost:

FREE

Credit Offered:

1 CME Credit

1 ABIM-MOC Point

1 Participation Credit